Target intelligence / Profile preview

Phosphoryl transfer enzyme

Molecular classification
Enzyme, Transferase, EC 2.7
01

Overview

Phosphoryl transfer enzymes are a broad and diverse class of proteins, including kinases and phosphatases, that catalyze the movement of a phosphate group from a donor molecule to an acceptor (Lassila, J. K., et al., Annu Rev Biochem, 2011). These enzymes play a pivotal role in cellular signaling, metabolism, and energy transfer by acting as molecular switches that regulate protein activity and localization (Westheimer, F. H., Science, 1987). They are formally classified under EC 2.7 and are essential for fundamental biological processes such as glycolysis, DNA replication, and the cell cycle (UniProt, 2024). Dysregulation of these enzymes, particularly protein kinases, is a primary driver of various diseases including cancer, where constitutive activation leads to uncontrolled cell proliferation and survival (Manning, G., et al., Science, 2002). Pharmacological intervention typically involves small-molecule inhibitors that compete with ATP or allosterically modulate the enzyme's conformation to prevent signaling (Zhang, J., et al., Nat Rev Cancer, 2009). Additionally, many antiviral therapies target viral phosphoryl transfer enzymes, such as polymerases, to inhibit genome replication (De Clercq, E., Nat Rev Drug Discov, 2002). However, the high structural conservation of the catalytic domains across this superfamily presents significant challenges for achieving drug selectivity and avoiding off-target toxicities (Knight, Z. A., et al., Nat Rev Cancer, 2005).

Other names
PhosphotransferaseKinasePhosphataseNucleotidyltransferasePhosphate transferase
02

Mechanism of action

Inhibition of phosphate group transfer by competing with the phosphate donor (typically ATP) or the substrate, or through allosteric modulation of the enzyme's catalytic conformation.

03

Biological functions

Signal transductionMetabolismEnergy homeostasisDNA replicationProtein phosphorylationCell cycle regulation
04

Disease associations

CancerDiabetes mellitusInflammatory diseaseNeurodegenerative diseaseCardiovascular diseaseViral infection
05

Safety considerations

Off-target kinase inhibition due to structural conservation of ATP-binding sitesCardiotoxicityHepatotoxicitySystemic metabolic disruptionAcquired drug resistance via gatekeeper mutations
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

Phospho-protein levels (e.g., p-ERK, p-AKT)Target mutation status (e.g., BRAF V600E, BCR-ABL)ATP/ADP ratiosEnzymatic activity assays

Beyond the preview

Go deeper on Phosphoryl transfer enzyme.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphoryl transfer enzyme.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call